These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9131258)

  • 1. Molecular determinants of drug binding and action on L-type calcium channels.
    Hockerman GH; Peterson BZ; Johnson BD; Catterall WA
    Annu Rev Pharmacol Toxicol; 1997; 37():361-96. PubMed ID: 9131258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.
    Striessnig J; Murphy BJ; Catterall WA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10769-73. PubMed ID: 1660150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels.
    Peterson BZ; Tanada TN; Catterall WA
    J Biol Chem; 1996 Mar; 271(10):5293-6. PubMed ID: 8621376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.
    Lacinová L; An RH; Xia J; Ito H; Klugbauer N; Triggle D; Hofmann F; Kass RS
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1472-9. PubMed ID: 10336541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the alpha1 subunit.
    Hockerman GH; Johnson BD; Abbott MR; Scheuer T; Catterall WA
    J Biol Chem; 1997 Jul; 272(30):18759-65. PubMed ID: 9228049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis.
    Peterson BZ; Johnson BD; Hockerman GH; Acheson M; Scheuer T; Catterall WA
    J Biol Chem; 1997 Jul; 272(30):18752-8. PubMed ID: 9228048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine.
    Miyashita Y; Furukawa T; Kamegaya E; Yoshii M; Nukada T
    Eur J Pharmacol; 2010 Apr; 632(1-3):14-22. PubMed ID: 20097194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of benz(othi)azepine-binding regions within L-type calcium channel alpha1 subunits.
    Kraus R; Reichl B; Kimball SD; Grabner M; Murphy BJ; Catterall WA; Striessnig J
    J Biol Chem; 1996 Aug; 271(33):20113-8. PubMed ID: 8702733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188.
    Sinnegger MJ; Wang Z; Grabner M; Hering S; Striessnig J; Glossmann H; Mitterdorfer J
    J Biol Chem; 1997 Oct; 272(44):27686-93. PubMed ID: 9346909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for inhibition of a voltage-gated Ca
    Tang L; Gamal El-Din TM; Swanson TM; Pryde DC; Scheuer T; Zheng N; Catterall WA
    Nature; 2016 Sep; 537(7618):117-121. PubMed ID: 27556947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines.
    Johnson BD; Hockerman GH; Scheuer T; Catterall WA
    Mol Pharmacol; 1996 Nov; 50(5):1388-400. PubMed ID: 8913371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
    Schuster A; Lacinová L; Klugbauer N; Ito H; Birnbaumer L; Hofmann F
    EMBO J; 1996 May; 15(10):2365-70. PubMed ID: 8665843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca(2+) channels.
    Hockerman GH; Dilmac N; Scheuer T; Catterall WA
    Mol Pharmacol; 2000 Dec; 58(6):1264-70. PubMed ID: 11093762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel.
    Ito H; Klugbauer N; Hofmann F
    Mol Pharmacol; 1997 Oct; 52(4):735-40. PubMed ID: 9380037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular studies on the voltage dependence of dihydropyridine action on L-type Ca2+ channels. Critical involvement of tyrosine residues in motif IIIS6 and IVS6.
    Bodi I; Yamaguchi H; Hara M; He M; Schwartz A; Varadi G
    J Biol Chem; 1997 Oct; 272(40):24952-60. PubMed ID: 9312099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site.
    Degtiar VE; Aczél S; Döring F; Timin EN; Berjukow S; Kimball D; Mitterdorfer J; Hering S
    Biophys J; 1997 Jul; 73(1):157-67. PubMed ID: 9199780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of interactions of dihydropyridines and phenylalkylamines with the inner pore of the L-type Ca2+ channel.
    Lipkind GM; Fozzard HA
    Mol Pharmacol; 2003 Mar; 63(3):499-511. PubMed ID: 12606756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
    Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
    Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.